2013
DOI: 10.3201/eid.1908.130257
|View full text |Cite
|
Sign up to set email alerts
|

Extended-Spectrum β-Lactamase–producingEnterobacteriaceaeamong Travelers from the Netherlands

Abstract: A prospective cohort study was performed among travelers from the Netherlands to investigate the acquisition of carbapenemase-producing Enterobacteriaceae (CP-E) and extended-spectrum β-lactamase–producing Enterobacteriaceae (ESBL-E) and associated risk factors. Questionnaires were administered and rectal swab samples were collected and tested before and after traveler return. Of 370 travelers, 32 (8.6%) were colonized with ESBL-E before trave,; 113 (30.5%) acquired an ESBL-E during travel, and 26 were still c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

19
112
2
2

Year Published

2014
2014
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 89 publications
(135 citation statements)
references
References 19 publications
19
112
2
2
Order By: Relevance
“…Travel to tropical regions like South Asia and Southeast Asia are one of the most frequently identified risk factors 17 , 18 , 21 , 23 , 25–29 , 31 . Acquisition rates as high as 93 and 91% have been found among subjects visiting Vietnam and India, respectively 28 .…”
Section: Risk Factors For Esbl-pe Acquisition Among Travellersmentioning
confidence: 99%
“…Travel to tropical regions like South Asia and Southeast Asia are one of the most frequently identified risk factors 17 , 18 , 21 , 23 , 25–29 , 31 . Acquisition rates as high as 93 and 91% have been found among subjects visiting Vietnam and India, respectively 28 .…”
Section: Risk Factors For Esbl-pe Acquisition Among Travellersmentioning
confidence: 99%
“…Paltansing en collega's melden dat van de Nederlandse reizigers in hun studie voorafgaand aan hun reis 8,6% drager was van ESBL-producerende Enterobacteriaceae, maar dat 30,5% deze opdeden tijdens hun reis of op hun bestemming, met als onafhankelijke risicofactoren 25 het reizen naar Zuiden Oost-Azië (Paltansing et al, 2013). Holmes et al (2016) voegen hier aan toe dat de verspreiding van carbapenem resistentievorming over de hele wereld sinds kort nog zorgwekkender is.…”
Section: Amr En Residuen Van Am-middelen and Globaliseringunclassified
“…Drug susceptibility Antimicrobial susceptibility profiles of identified bacterial pathogens and carriage of multidrug resistant pathogens should be taken into consideration in decision making for empirical antimicrobial therapy [50][51][52]. Drug resistance in tuberculosis should be detected rapidly, and appropriate treatment options with the alternative second and third line anti-tuberculosis drugs (fluoroquinolones, ethionamide, cycloserine, amikacin, linezolid) is crucial in the management of multidrug resistant tuberculosis [53].…”
Section: Patient Managementmentioning
confidence: 99%